Recombinant Human Chymotrypsin C/CTRC Protein, CF

R&D Systems | Catalog # 6907-SE

R&D Systems
Loading...

Key Product Details

  • R&D Systems CHO-derived Recombinant Human Chymotrypsin C/CTRC Protein (6907-SE)
  • Quality control testing to verify active proteins with lot specific assays by in-house scientists
  • All R&D Systems proteins are covered with a 100% guarantee

Source

CHO

Accession Number

Applications

Enzyme Activity
Loading...

Product Specifications

Source

Chinese Hamster Ovary cell line, CHO-derived human Chymotrypsin C/CTRC protein
Met1-Leu268, with a C-terminal 6-His tag

Purity

>95%, by SDS-PAGE under reducing conditions and visualized by Colloidal Coomassie® Blue stain at 5 μg per lane.

Endotoxin Level

<1.0 EU per 1 μg of the protein by the LAL method.

N-terminal Sequence Analysis

Cys17

Predicted Molecular Mass

28.8 kDa

SDS-PAGE

33-40 kDa, reducing conditions

Activity

Measured by its ability to cleave the fluorogenic peptide substrate, SUC-Ala-Ala-Pro-Phe-AMC.
The specific activity is >400 pmol/min/μg, as measured under the described conditions.

Formulation, Preparation, and Storage

6907-SE
Formulation Supplied as a 0.2 μm filtered solution in Tris and NaCl.
Shipping The product is shipped with polar packs. Upon receipt, store it immediately at the temperature recommended below.
Stability & Storage Use a manual defrost freezer and avoid repeated freeze-thaw cycles.
  • 6 months from date of receipt, -20 to -70 °C as supplied.
  • 3 months, -20 to -70 °C under sterile conditions after opening.

Background: Chymotrypsin C/CTRC

Chymotrypsin C (CTRC), also known as caldecrin, is a serine protease and a member of the peptidase S1 family. The CTRC gene encodes a serum calcium‑decreasing factor that has chymotrypsin-like protease activity (1). CTRC has broad substrate specificity, but prefers to cleave on the carboxyl side of hydrophobic residues. The enzyme is expressed primarily in the pancreas, and is secreted into the digestive tract. CTRC is a key regulator of activation and degradation of cationic trypsinogen (2, 3). The inappropriate activation of cationic trypsinogen can contribute to the development of pancreatitis (2, 3). CTRC inhibits osteoclast differentiation by suppression of NFATc1 function by a mechanism independent of its proteolytic activity (4).

References

  1. Tomomura, A. et al. (1995) J. Biol. Chem. 270:30315.
  2. Szmola, R. and M. Sahin-Toth (2007) Proc. Natl. Acad. Sci. USA 104:11227.
  3. Nemoda, Z. and M. Sahin-Toth (2006) J. Biol. Chem. 281:11879.
  4. Hasegawa, H. et al. (2010) J. Biol. Chem. 285:25448.

Alternate Names

Caldecrin, CLCR, CTRC, ELA4, Elastase IV

Entrez Gene IDs

11330 (Human); 76701 (Mouse)

Gene Symbol

CTRC

UniProt

Additional Chymotrypsin C/CTRC Products

Product Documents for Recombinant Human Chymotrypsin C/CTRC Protein, CF

Certificate of Analysis

To download a Certificate of Analysis, please enter a lot or batch number in the search box below.

Note: Certificate of Analysis not available for kit components.

Product Specific Notices for Recombinant Human Chymotrypsin C/CTRC Protein, CF

Coomassie is a registered trademark of Imperial Chemical Industries Ltd.

For research use only

Related Research Areas

Citations for Recombinant Human Chymotrypsin C/CTRC Protein, CF

Customer Reviews for Recombinant Human Chymotrypsin C/CTRC Protein, CF

There are currently no reviews for this product. Be the first to review Recombinant Human Chymotrypsin C/CTRC Protein, CF and earn rewards!

Have you used Recombinant Human Chymotrypsin C/CTRC Protein, CF?

Submit a review and receive an Amazon gift card!

$25/€18/£15/$25CAN/¥2500 Yen for a review with an image

$10/€7/£6/$10CAN/¥1110 Yen for a review without an image

Submit a review
Amazon Gift Card

Protocols

View specific protocols for Recombinant Human Chymotrypsin C/CTRC Protein, CF (6907-SE):

Materials
  • Activation Buffer: 50 mM Tris, 10 mM CaCl2, 150 mM NaCl, pH 7.5 (TCN)
  • Assay Buffer: 25 mM Tris, 0.5 mM CaCl2, pH 8.0
  • Recombinant Human Chymotrypsin C/CTRC (rhCTRC) (Catalog # 6907-SE)
  • Trypsin (Sigma, Catalog # T1426)
  • Recombinant Human Serpin F2/ alpha 2‑Antiplasmin (rhSerpin F2) (Catalog # 1470-PI) (optional)
  • Substrate: Suc-AAPF-AMC (Bachem, Catalog # I-1465), 10 mM stock in DMSO
  • F16 Black Maxisorp Plate (Nunc, Catalog # 475515)
  • Fluorescent Plate Reader (Model: SpectraMax Gemini EM by Molecular Devices) or equivalent
  1. Dilute rhCTRC to 200 µg/mL in Activation Buffer.
  2. Dilute Trypsin to 0.4 µg/mL in Activation Buffer.
  3. Combine equal volumes of 200 µg/mL rhCTRC and 0.4 µg/mL Trypsin.
  4. Incubate at 37 °C for 1 hour.
  5. Optional: Stop Trypsin activity by adding rhSerpin F2 to a final concentration of 4 µg/mL.
  6. Dilute rhCTRC to 1 ng/µL in Assay Buffer.
  7. Dilute Substrate to 200 µM in Assay Buffer.
  8. Load into a black well plate 50 µL of the 1 ng/µL rhCTRC and start the reaction by adding 50 µL of 200 µM Substrate. For a Substrate Blank, load Assay Buffer in place of the rhCTRC.
  9. Read at excitation and emission wavelengths of 380 nm and 460 nm (top read), respectively, in kinetic mode for 5 minutes.
  10. Calculate specific activity:

     Specific Activity (pmol/min/µg) =

Adjusted Vmax* (RFU/min) x Conversion Factor** (pmol/RFU)
amount of enzyme (µg)

     *Adjusted for Substrate Blank
     **Derived using calibration standard 7-Amino, 4-Methyl Coumarin (AMC) (Sigma, Catalog # A9891).

Per Well:

  • rhCTRC: 0.050 µg
  • Substrate: 100 µM

FAQs

No product specific FAQs exist for this product.

View all FAQs for Proteins and Enzymes
Loading...